An additional study showed that CD44 knockdown causes breast cancer stem cells (BCSCs) to differentiate into non-BCSCs with lower tumorigenic potential, and CD44 knockdown BCSCs extended S phase similar to non-BCSCs [42]. The gene discussed is CD44; the disease is breast cancer.